Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Avista, Nordic buy BMS's wound care unit ConvaTec for $4.1bn

Executive Summary

Private equity groups Nordic Capital and Avista Capital Partners agreed to acquire Bristol-Myers Squibb's ConvaTec for $4.1bn, paying three-and-a-half times the wound and ostomy care unit's 2007 revenues. ConvaTec will operate as an independent company and retain its current CEO.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Divestiture/Spin-Out
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies